Meaghan Westenhaver
Family Medicine · Johns Creek, GANPI 1770297509
Payments from drug & device makers
Across 176 payments — averaging $18.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$518
- Lilly USA, LLC$456
- Novo Nordisk$364
- AbbVie$242
- Esperion Therapeutics, Inc.$232
- Corium, LLC$226
- plus $1K from 16 others
What the payments were for
- Food & beverage$3,186100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 29 | $518 |
| Lilly USA, LLC | 26 | $456 |
| Novo Nordisk | 20 | $364 |
| AbbVie | 17 | $242 |
| Esperion Therapeutics, Inc. | 13 | $232 |
| Corium, LLC | 9 | $226 |
| Noven Therapeutics, LLC | 9 | $199 |
| Exact Sciences | 9 | $191 |
| Amgen | 9 | $138 |
| Idorsia Pharmaceuticals US Inc | 6 | $96 |
| Tris Pharma Inc | 5 | $80 |
| Astellas Pharma US Inc | 4 | $75 |
| Dexcom, Inc. | 4 | $68 |
| Verity Pharmaceuticals Inc. | 3 | $57 |
| Tolmar, Inc. | 3 | $55 |
| Pfizer | 3 | $53 |
| GSK | 2 | $34 |
| Boston Scientific | 1 | $33 |
| Bausch Health US, LLC | 1 | $20 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Nevro Corp. | 1 | $16 |
| Merck | 1 | $14 |
How this compares
$3,186 in reported general payments places this provider in the 75th percentile of 3,111 family medicine providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 14 | $16,590 |
| FarxigaDapagliflozin Propanediol | 12 | $13,469 |
| SynthroidLevothyroxine Sodium | 13 | $1,636 |
| Bupropion XlBupropion Hcl | 17 | $864 |
| Levothyroxine Sodium | 78 | $727 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 29 | $689 |
| Atorvastatin Calcium | 87 | $685 |
| Rosuvastatin Calcium | 90 | $586 |
| Zolpidem Tartrate | 58 | $546 |
| Tamsulosin Hcl | 19 | $496 |
| ValacyclovirValacyclovir Hcl | 13 | $493 |
| Escitalopram Oxalate | 22 | $376 |
| Celecoxib | 12 | $327 |
| Losartan Potassium | 40 | $302 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 44 | $286 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $456 | $16,59014 claims |
| AstraZenecaFarxiga | $518 | $13,46912 claims |
| AbbVieSynthroid | $242 | $1,63613 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,111 family medicine providers in Georgia.
Other family medicine in Johns Creek
- Joseph SurberColumbus$16.6M
- Angela RitterGainesville$15.8M
- Jeffrey KingsleyColumbus$8.1M
- Christopher OldfieldSavannah$6.4M
- Darrell MurrayAtlanta$3.9M
- Ben ThomasAtlanta$3.2M
- Debbie HaginsSavannah$2.1M
- Aziz PiraniLilburn$2.1M
- Nadia CameronAtlanta$2.1M
- John LentzSnellville$1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.